- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 62.80% based on similar historical setup states.
ENSG
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
The Ensign Group Inc · Healthcare · Medical Care Facilities
Latest close
178.2 USD
3.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.9% below the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned 3.0%, after a 5.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal.
Setup score
46
out of 100
Latest Close
178.2 USD
31 Jul 2026
1W Return
3.0%
latest completed week
4W Return
5.9%
short-term follow-through
12W Return
4.0%
quarterly tape
Trend Breadth
75.0%
39 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.0%
Latest completed week; four-week move 5.9%.
Indicator stack
41/48
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 62.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
37/100 conviction; expected move 7.6%.
News sentiment
54/100
55 relevant articles in the latest sentiment read.
Event risk
23 Jul
Latest stored earnings date was 23 Jul 2026.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.9% below the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned 3.0%, after a 5.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1312-week average 0.30
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.9% over four weeks, 4.0% over 12 weeks, and 17.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year39
Trend breadth75.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.36Latest activity-pressure read.
Pressure change53.3%Four-week change in activity pressure.
Leadership-9.93Latest relative-leadership reading.
RS change45.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 100%
Model confidence 96%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework29/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 27.8x Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- 19.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 6.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 13.9% Gross profit retained from each unit of revenue.
- Operating margin
- 9.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 14.8% Free cash flow generated from revenue.
- Return on invested capital
- 9.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.2% Latest one-year revenue growth.
- EPS growth
- 17.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 40.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- -0.2% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
ENSG shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.57, expected move of 7.6%, and Sharemaestro trend signal inactive.
Conviction37/100
Expected move7.6%
Put/call volume0.57
Insider activity6 / 14
6 acquisitions and 14 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment54/100
Weighted news tone is neutral across 55 relevant articles.
21 positive · 24 neutral · 10 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings23 JulLatest stored earnings date was 23 Jul 2026.
Options expected move7.6%Nearest-chain priced movement where available.
52-week drawdown-18.2%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher16 of 2610 weeks finished lower.
Best week+15.2%Week of 6 Feb.
Worst week-12.3%Week of 12 Jun.
Latest week+3.0%Week of 31 Jul.
Shape of recent returns
Strong gains3
Modest gains13
Flat weeks0
Modest losses6
Sharp losses4
Recent vol4.8%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average-1.5%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD78.0%positive activity pressure
RS49.0%positive relative leadership
Four-week leaders
IndustryUS Medical Care Facilities
4-week rank9 / 44
Group average-3.0%
Trend breadth70.5%
Trend70.5%active weekly trend signals
MD84.1%positive activity pressure
RS54.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape44/100
Trend, activity pressure, participation, and risk combine to a 44/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.13; No reversal markers Next-Week ExpectancyPositive 62.80%Next-week expectancy is positive with a 62.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors23/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 74; Small Cap Core rank 88 SVQF29/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 517.5 of 726 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options46/100ENSG shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.57, expected move of 7.6%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 7.6% Sentiment54/100Weighted news tone is neutral across 55 relevant articles.
Truist Raises Price Target on Ensign Group to $207 From $202, Keeps Hold Rating Insiders6 / 146 acquisitions and 14 disposals in the latest 180-day insider tape.
Earnings23 JulLatest stored earnings date was 23 Jul 2026.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 178.2 USD | 3.0% | 183.6 USD | 144.8 USD | -0.36 | -9.93 | 3.0M | Off |
| 24 Jul 2026 | 173.0 USD | 1.0% | 183.4 USD | 144.3 USD | -0.60 | -12.16 | 2.0M | Off |
| 17 Jul 2026 | 171.3 USD | 1.6% | 183.5 USD | 143.7 USD | -0.65 | -14.49 | 2.5M | Off |
| 10 Jul 2026 | 168.6 USD | 0.2% | 183.9 USD | 143.2 USD | -0.75 | -19.32 | 2.5M | Off |
| 3 Jul 2026 | 168.2 USD | 3.2% | 184.1 USD | 142.7 USD | -0.78 | -18.19 | 3.1M | Off |
| 26 Jun 2026 | 163.0 USD | 6.1% | 184.4 USD | 142.2 USD | -0.81 | -20.24 | 11.8M | Off |
| 19 Jun 2026 | 153.6 USD | 2.9% | 185.2 USD | 141.8 USD | -1.00 | -28.46 | 4.8M | Off |
| 12 Jun 2026 | 149.3 USD | -12.3% | 186.2 USD | 141.4 USD | -1.04 | -28.99 | 8.1M | Off |
| 5 Jun 2026 | 170.2 USD | 1.6% | 187.1 USD | 141.0 USD | -1.05 | -17.61 | 2.7M | Off |
| 29 May 2026 | 167.6 USD | -2.5% | 187.5 USD | 140.5 USD | -1.03 | -22.78 | 1.9M | Off |
| 22 May 2026 | 171.9 USD | -3.2% | 187.9 USD | 140.0 USD | -0.82 | -18.82 | 2.5M | Off |
| 15 May 2026 | 177.6 USD | 3.6% | 188.4 USD | 139.5 USD | -0.60 | -15.34 | 3.5M | Off |
| 8 May 2026 | 171.4 USD | -6.7% | 188.5 USD | 139.0 USD | -0.42 | -18.77 | 3.0M | Off |
| 1 May 2026 | 183.6 USD | -2.9% | 188.6 USD | 138.4 USD | -0.20 | -8.40 | 2.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.